Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 9/20 | 0.52 |
| ▸ | HPGD | P15428 | 8/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6719674 | 0.88 | L3MBTL1 (0.46) | MAPTL3MBTL1HPGDRAB9ANPC1 | |
| SCHEMBL6720004 | 0.86 | L3MBTL1 (0.42) | MAPTL3MBTL1HPGDRAB9ANPC1 | |
| SCHEMBL6717134 | 0.85 | L3MBTL1 (0.47) | MAPTL3MBTL1HPGDRAB9ANPC1 | |
| SCHEMBL6728447 | 0.81 | NPSR1 (0.50) | MAPTL3MBTL1HPGDRAB9ANPC1 | |
| SCHEMBL6721777 | 0.80 | MAPT (0.51) | MAPTL3MBTL1HPGDATMIDO1 | |
| SCHEMBL6721581 | 0.80 | MAPT (0.54) | MAPTL3MBTL1HPGDRAB9ANPC1 | |
| SCHEMBL1941923 | 0.76 | IDO1 (0.53) | L3MBTL1SMN1; SMN2IDO1RENHTR1A | |
| SCHEMBL6717628 | 0.76 | SMN1; SMN2 (0.43) | MAPTL3MBTL1HPGDSMN1; SMN2MAPK1 | |
| SCHEMBL6728676 | 0.75 | MAPT (0.52) | MAPTL3MBTL1HPGDRAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL2473227 | 0.75 | IDO1 (0.54) | MAPTSMN1; SMN2ALDH1A1TDP1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040214832-A1 | Piperazine derivative renin inhibitors | WARNER-LAMBERT COMPANY LLC | 2004-10-28 | — | — | US | disclosed |
| WO-2004089915-A1 | PIPERAZINE DERIVATIVE RENIN INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214832-A1 | Piperazine derivative renin inhibitors | REN, ACE, AGTR2 | MAPT 3937/4885L3MBTL1 4859/4885HPGD 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.